US2016244723A1PendingUtilityA1

Cardiac stem cells and uses of same in cardiac repair

Assignee: UNIV DEGLI STUDI ROMA LA SAPIENZAPriority: Jul 31, 2003Filed: Jan 7, 2016Published: Aug 25, 2016
Est. expiryJul 31, 2023(expired)· nominal 20-yr term from priority
A61K 35/12A61P 9/00C12N 2501/175C12N 2501/11A61P 9/10C12N 2501/115C12N 2533/32C12N 5/0657C12N 5/069
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Method for the isolation, expansion and preservation of cardiac stem cells from human or animal tissue biopsy samples to be employed in cell transplantation and functional repair of the myocardium or other organs. Cells may also be used in gene therapy for treating cardiomyopathies, for treating ischemic heart diseases and for setting in vitro models to study drugs.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A procedure to obtain cardiospheres able to repair damaged myocardiac tissue, comprising:
 a. take a biopsy sample of cardiac tissue and keep it in an appropriate culture medium;   b. treat the specimen under appropriate conditions with mild mechanical, chemical or enzymatic techniques to obtain fragments of the sample size large enough to allow diffusion of nutrients present in the medium;   c. fix the tissue fragments to appropriate solid supports and maintain them in a medium containing serum and/or adequate growth factors;   d. allow the cells to grow, changing the medium partially or completely, until multicellular structures form that are either weekly adherent or do not adhere to the support;   e. separate these multicellular structures from the rest of the medium;   f. treat the structures by mild dissociation until most of the small phase bright spherical cells detach but maintain their morphologic and functional characteristics;   g. plate the cells on culture substrates treated with polylysine or other agents promoting the adhesion of the culture to the support in a medium containing at least the minimal essential constituents for the growth of mammalian cells;   h. possibly repeat steps d) to g) at least once;   i. select the cells that aggregate in phase bright spheroid formations (cardiospheres);   j. selectively promote the formation of new Cardiospheres by mild dissociation and new formation;   k. selectively cryopreserved the Cardiospheres for use after thawing.

Join the waitlist — get patent alerts

Track US2016244723A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.